• 2009

Company Description

Aros Pharma ApS develops therapies for reducing the pain associated with Irritable Bowel Syndrome (IBS)

Aros Pharma is developing a new effective therapy reducing the pain associated with Irritable Bowel Syndrome (IBS). The company has acquired all rights to a new chemical entity that can negatively modulate the activity of acid sensors in the gastrointestinal tract. These acid sensors are believed to play a central role in pain associated with IBS.